Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Dill

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Oncology Letters|August 27, 2025
Radiomics-based prediction of HCC response to atezolizumab/bevacizumabIsaac Rodriguez, Abhinay Vellala, Timo Itzel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinomaKaiyu Xu, Annika Kessler, Federico Nichetti, et al.
Nature Cell Biology|April 19, 2016
The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and sizeLara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Nature Cell Biology|October 28, 2016
Corrigendum: The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and sizeLara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.
Cell Stem Cell|April 5, 2024
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivoKenji Namoto, Clara Baader, Vanessa Orsini, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Oncology Letters|August 27, 2025
Radiomics-based prediction of HCC response to atezolizumab/bevacizumabIsaac Rodriguez, Abhinay Vellala, Timo Itzel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinomaKaiyu Xu, Annika Kessler, Federico Nichetti, et al.
Nature Cell Biology|April 19, 2016
The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and sizeLara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Nature Cell Biology|October 28, 2016
Corrigendum: The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and sizeLara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.
Cell Stem Cell|April 5, 2024
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivoKenji Namoto, Clara Baader, Vanessa Orsini, et al.
Pageof 5